Kolexia
Dumas Elise
Immunologie
Institut Curie
Saint-Cloud, France
26 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Pathologic Complete Response Tumeurs du sein triple-négatives Urgences Carcinome pulmonaire non à petites cellules Seconde tumeur primitive Récidive tumorale locale Maladie résiduelle Tumeurs du poumon

Industries

{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

NeoFit: Digital Phenotyping (Physical Activity, Heart Rate, Sleep) in Young Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
Essai Clinique (Institut Curie)   26 janvier 2024
Early morning immune checkpoint blockade and overall survival of patients with metastatic cancer: An In-depth chronotherapeutic study.
European journal of cancer (Oxford, England : 1990)   22 janvier 2024
Étude chronothérapeutique de la perfusion d’inhibiteurs de checkpoint chez des patients atteints de cancer métastatique
Médecine du Sommeil   01 décembre 2023
Treatments During Pregnancy Targeting ERBB2 and Outcomes of Pregnant Individuals and Newborns.
JAMA network open   02 octobre 2023
Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses.
Nature biotechnology   25 septembre 2023
Evolution of synchronous female bilateral breast cancers and response to treatment.
Nature medicine   06 mars 2023
Contraception in breast cancer survivors from the FEERIC case-control study (performed on behalf of the Seintinelles research network).
Breast (Edinburgh, Scotland)   31 décembre 2022
No Impact of Seasonality of Diagnoses on Baseline Tumor Immune Infiltration, Response to Treatment, and Prognosis in BC Patients Treated with NAC.
Cancers   23 juin 2022
The French Early Breast Cancer Cohort (FRESH): A Resource for Breast Cancer Research and Evaluations of Oncology Practices Based on the French National Healthcare System Database (SNDS).
Cancers   27 mai 2022
Digital phenotyping in young breast cancer patients treated with neoadjuvant chemotherapy (the NeoFit Trial): protocol for a national, multicenter single-arm trial.
BMC cancer   04 mai 2022